Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
. Prospects
The global pandemic caused by the Covid-19 virus have created an exponential increase in demand
for medical gloves which benefited many manufacturers including Careplus. As an essential product
manufacturer, our operation was unaffected by the enforcement of the Movements Control Order or
MCO from March 18, 2020 except for the strict compliance to the standard operating procedures or
SOP to ensure new safety measures and personal hygiene standards are in place for all the
production workers and staff in the workplace and foreign workers dormitories. The average selling
prices surged during the pandemic period. The Group expects a strong positive result in coming
quarters. The business prospects remain good.
We are optimistic that the group will perform better after the completion of purchase of the remaining
shares of Careglove from AJJ and the recent JV of Careplus (M) Sdn Bhd with Ansell Services
(Asia) Sdn Bhd.
Careglove made a profit before tax of RM980,000 in Q1 of FY 2020. As a wholly-owned subsidiary
of Careplus, it is now in a better position to explore new business opportunities globally. In the case
of Careplus (M), the partnership with Ansell will enable us to produce higher value products and
increase our surgical gloves market share.
